CLOs on the Move


 
Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and chronic pain. We leverage Nektar`s proprietary and proven chemistry platform in the discovery and design of our new drug candidates.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.nektar.com
  • 455 Mission Bay Boulevard South
    San Francisco, CA USA 94158
  • Phone: 415.482.5300

Executives

Name Title Contact Details
Mark Wilson
Vice President and General Counsel Profile
Wen Liu
VP Regulatory Affairs Profile
Susan Evans
Vice President Intellectual Property Profile
Carlo Difonzo
VP, Regulatory Affairs and Product Safety Profile

Similar Companies

NLS Pharmaceutics

We design affordable, safe and effective drugs to safeguard and empower the brain throughout all stages of life. Our aim is to improve quality of life and longevity.

Indago

Indago is developing smart surgical tools that enable physicians to focus on healthcare, not hardware. Our mission: to create the OR of the future.

CAREstream America

Specializing in Respiratory, Patient Monitoring, Diagnostic, Anesthesia, Ventilation Biomedical and Plastic Surgery Products.

Symphogen

Symphogen, Inc. is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Vindico Medical Education

Vindico Medical Education is a Thorofare, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.